Stay updated on Uproleselan High Dose Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan High Dose Combo in AML Clinical Trial page.

Latest updates to the Uproleselan High Dose Combo in AML Clinical Trial page
- Check5 days agoChange DetectedThe history page adds a new revision entry 'Revision: v3.4.3'. The previous 'Revision: v3.4.2' is removed from the list.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedA new site revision, v3.4.2, was added to the history, and the previous funding-status notice and the v3.4.1 entry were removed, representing administrative updates that do not affect study data or core page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange DetectedA site-wide funding notice was added and the latest revision version v3.4.1 was introduced, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedAdded a Show glossary option and references to green/red highlights for changes, along with explanatory copy; revision labels were updated to v3.4.0 and No FEAR Act data wording was adjusted.SummaryDifference0.6%

- Check62 days agoChange DetectedA new revision entry v3.3.4 was added to the record history, and the previous revision v3.3.3 was removed from the list.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Uproleselan High Dose Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan High Dose Combo in AML Clinical Trial page.